Evidence map›Paper›PMID 30720769›Full record

ArticleJournal of clinical medicine2019

Surface Modification of Electrospun Scaffolds for Endothelialization of Tissue-Engineered Vascular Grafts Using Human Cord Blood-Derived Endothelial Cells.

Diana Catalina Ardila, Jr-Jiun Liou, David Maestas, Marvin J Slepian, Michael Badowski, William R. Wagner, David Harris, Jonathan P Vande Geest

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Mechanical alterations of electrospun poly(ϵ-caprolactone) in response to convective thermobonding.Journal of biomedical materials research. Part B, Applied biomaterials · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Diana Catalina ArdilaDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA. dca13@pitt.edu.
Jr-Jiun LiouDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA. jrl101@pitt.edu.ORCID 0000-0002-8800-9557
David MaestasDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21231, USA. dmaesta1@jhmi.edu.
Marvin J SlepianSarver Heart Center, The University of Arizona, Tucson, AZ 85721, USA. slepian@email.arizona.edu.
Michael BadowskiArizona Health Science Center Biorepository, University of Arizona, Tucson, AZ 85724, USA. badowski@email.arizona.edu.
William R. WagnerDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA. wagnerwr@upmc.edu.
David HarrisArizona Health Science Center Biorepository, University of Arizona, Tucson, AZ 85724, USA. davidh@email.arizona.edu.
Jonathan P Vande GeestDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15219, USA. jpv20@pitt.edu.
University of Pittsburgh · USUniversity of Arizona · USJohns Hopkins University · US

Funding

Preclinical assessment of a compliance matched biopolymer vascular graftR56HL136517 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VANDE GEEST, JONATHAN PIETER · 2017 to 2017
$673k
National Science Foundation 1337371NHLBI NIH HHS R56 HL136517NIH HHS 1R56HL136517-01NIH HHS 5T32EB001026
6 · The paper itself

Abstract

Tissue engineering has gained attention as an alternative approach for developing small diameter tissue-engineered vascular grafts intended for bypass surgery, as an option to treat coronary heart disease. To promote the formation of a healthy endothelial cell monolayer in the lumen of the graft, polycaprolactone/gelatin/fibrinogen scaffolds were developed, and the surface was modified using thermoforming and coating with collagen IV and fibronectin. Human cord blood-derived endothelial cells (hCB-ECs) were seeded onto the scaffolds and the important characteristics of a healthy endothelial cell layer were evaluated under static conditions using human umbilical vein endothelial cells as a control. We found that polycaprolactone/gelatin/fibrinogen scaffolds that were thermoformed and coated are the most suitable for endothelial cell growth. hCB-ECs can proliferate, produce endothelial nitric oxide synthase, respond to interleukin 1 beta, and reduce platelet deposition.

Indexed as

endothelializationhuman cord blood-derived endothelial cellsumbilical cord bloodvascular graftVascular tissue engineering

Identifiers

PMID30720769
PMCPMC6416564
OpenAlexW2914867496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.